Olympus to pay $646M to settle kickback charges, FDA approves Allergan's new drug application & more – 7 GI company key notes

Here are seven recent news updates on key gastroenterology and endoscopy companies.

Olympus of the Americas will pay $646 million in a civil and criminal penalties suit to settle kickback charges.

Healthmark Industries added the Small Bore Endoscope Channel Brush to its ProSys instrument care line.

Allergan received an 'acceptable for filing' letter from the FDA for its abbreviated new drug application seeking approval to market Rifaximin Tablets.

Globally, surgeons have performed more than 200 procedures with Medigus' Ultrasonic Surigcal Endostapler.

Tifton (Ga.) Endoscopy Center is one of the first centers in the state offering EndoChoice's The Fuse system.

Solos Endoscopy renewed the Establishment Registration and Device Listing of its endoscopic instruments with the FDA.

The FDA reiterated its November 2015 Safety Communication recommending that organizations using Custom Ultrasonics' Automated Endoscope Reprocessors transition to alternative methods to reprocess flexible endoscopes.

More articles on GI/endoscopy:
Healthmark introduces endoscope brush
AGA selects Dr. Nelson Garcia for future leaders program
5 GI physicians in the news

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers